• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

American Society of Hematology

Werewolf moon wolf howl night
Biotech

Jazz, Werewolf to howl at the moon in $1.26M biobucks deal

Jazz Pharmaceuticals and Werewolf Therapeutics will work together in a deal that gives the latter $15 million upfront.
Annalee Armstrong Apr 7, 2022 9:35am
Takeda US facility

Takeda previews early data for 'Wave 2' multiple myeloma med

Dec 13, 2021 7:00pm
red blood cells

UniQure/CSL hem B gene therapy curbs bleeding in phase 3

Dec 8, 2020 10:10am
Novartis headquarters

Novartis' asciminib tops Pfizer's Bosulif in head-to-head trial

Dec 8, 2020 10:00am
Mouse

CRISPR-edited CAR-Ts show enhanced activity in leukemia models

Dec 7, 2020 8:45am
Allogene Therapeutics Co-Founders Arie Belldegrun and David Chang

Allogene CAR-T posts 60% response rate in competitive BCMA field

Dec 7, 2020 8:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings